Status:
UNKNOWN
Orthophonic and / or Proprioceptive Treatment of Developmental Dyslexia.
Lead Sponsor:
Scalab CNRS 9193
Conditions:
Developmental Dyslexia
Eligibility:
All Genders
9-14 years
Phase:
NA
Brief Summary
To show the interest of the association of proprioceptive and orthophonic care of dyslexic children. The assumption is that proprioceptive support by correcting a centrally located spatial localizatio...
Eligibility Criteria
Inclusion
- Developmental dyslexia, (CIM-10)
- Having benefited from 2 years of speech therapy.
- Pathological reading delay of more than 24 months or -2 standard deviations.
- Either in the course of orthophonic care, or having stopped any orthophonic care.
Exclusion
- Refractive correction above +/- 1.5 diopters.
- Absence of binocular vision.
- Amblyopia.
- Convulsion.
Key Trial Info
Start Date :
February 17 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 10 2020
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT03448237
Start Date
February 17 2018
End Date
October 10 2020
Last Update
March 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Scalab CNRS 9193
Villeneuve-d'Ascq, Haut de France, France, 59653